Key result
Digoxin is a safe and readily available agent that may be beneficial for acute and chronic heart failure syndromes, warranting further investigation in large clinical trials.
Why the study?
Does digoxin provide benefit in patients with acute and chronic heart failure syndromes?
Population
Patients with acute and chronic heart failure syndromes
Design
Review
Authors
Loading...
Does not support routine HF use; leaves open benefit in contemporary populations pending RCTs.
Does digoxin provide benefit in patients with acute and chronic heart failure syndromes?
Digoxin remains a readily available and potentially beneficial treatment for acute and chronic heart failure, though further large clinical trials are warranted.
Gheorghiade et al. (2009) conducted a review in Acute and chronic heart failure. Digoxin was evaluated. Digoxin is a safe and readily available agent that may be beneficial for acute and chronic heart failure syndromes, warranting further investigation in large clinical trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: